Monocyte Immune Response

Shares of Prima BioMed Ltd (ADR) (NASDAQ: PBMD) were trading higher by more than 10 percent early Monday morning after the Australia-based biotechnology company announced it has received a patent from the Japanese Patent Office. Related Link: Allergan Gets Positive Opinion From EU's CHMP For Its...